🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this clinical study is to evaluate the safety and immunogeni...
Status
Completed
Location
Hvidovre Hospital ( Site 0003)
Start Date
2019-08-28
Trial ID
NCT04016714
Treatments Being Tested
This study will evaluate the immunogenicity, safety, and tolerability of VA...
Status
Completed
Location
Multiple Locations
Start Date
2014-03-07
Trial ID
NCT02062502
Treatments Being Tested
This study will evaluate the immunogenicity, safety, and tolerability of VA...
Status
Completed
Location
Alabama Clinical Therapeutics ( Site 0018)
Start Date
2017-10-17
Trial ID
NCT03239873
Treatments Being Tested
This is a study to evaluate the immune response and safety of GSK Biologica...
Status
Completed
Location
GSK Investigational Site
Start Date
2003-10-06
Trial ID
NCT00197015
The purpose of this study is to evaluate the safety, tolerability, and immu...
Status
Completed
Location
Alabama Clinical Therapeutics ( Site 0159)
Start Date
2019-06-19
Trial ID
NCT03893448
Treatments Being Tested
The goal of this study is to evaluate the safety, tolerability, and immunog...
Status
Completed
Location
Alabama Clinical Therapeutics ( Site 0015)
Start Date
2018-10-18
Trial ID
NCT03620162
Treatments Being Tested
This study is a Phase 3, randomized, modified double-blind study which aims...
Status
Active Not Recruiting
Location
Kaiser Permanente - Los Angeles Medical Center- Site Number : 8400025
Start Date
2025-02-27
Trial ID
NCT06824181
This study will compare ProQuad™ and concomitant administration of M-M-R™ I...
Status
Terminated
Location
Multiple Locations
Start Date
2008-02
Trial ID
NCT00839917
This study is the first clinical study of first-line treatment of head and ...
Status
Completed
Location
the Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Start Date
2021-06-24
Trial ID
NCT05156970
Treatments Being Tested
RATIONALE: Antithymocyte globulin, clofarabine, and rituximab may stop the ...
Status
Terminated
Location
Masonic Cancer Center at University of Minnesota
Start Date
2008-01
Trial ID
NCT00617929
Treatments Being Tested